Dynamic Interplay between O-Linked N-Acetylglucosaminylation and Glycogen Synthase Kinase-3-dependent Phosphorylation

Haltiwanger, 1992, Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylglucosaminyltransferase, J. Biol. Chem., 267, 9005, 10.1016/S0021-9258(19)50380-5

Gao, 2001, Dynamic O-glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain, J. Biol. Chem., 276, 9838, 10.1074/jbc.M010420200

Hart, 1997, Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins, Annu. Rev. Biochem., 66, 315, 10.1146/annurev.biochem.66.1.315

Vosseller, 2002, Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes, Proc. Natl. Acad. Sci. U. S. A., 99, 5313, 10.1073/pnas.072072399

Yang, 2002, Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression, Cell, 110, 69, 10.1016/S0092-8674(02)00810-3

James, 2002, Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promotor activation, Diabetes, 51, 1146, 10.2337/diabetes.51.4.1146

Slawson, 2005, Perturbations in O-linked β-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis, J. Biol. Chem., 280, 32944, 10.1074/jbc.M503396200

Zhang, 2003, O-GlcNAc modification is an endogenous inhibitor of the proteasome, Cell, 115, 715, 10.1016/S0092-8674(03)00974-7

Gong, 2005, Post-translational modifications of tau protein in Alzheimer's disease, J. Neural Transm., 112, 813, 10.1007/s00702-004-0221-0

Zachara, 2004, Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells, J. Biol. Chem., 279, 30133, 10.1074/jbc.M403773200

McClain, 1996, Hexosamines and insulin resistance, Diabetes, 45, 1003, 10.2337/diab.45.8.1003

Liu, 2004, O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 101, 10804, 10.1073/pnas.0400348101

Comer, 2001, Reciprocity between O-GlcNAc and O-phosphate on the C-terminal repeat domain of RNA polymerase II, Biochemistry, 40, 7845, 10.1021/bi0027480

Chou, 1995, c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas, J. Biol. Chem., 270, 18961, 10.1074/jbc.270.32.18961

Cheng, 2000, Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor β, Biochemistry, 39, 11609, 10.1021/bi000755i

Musicki, 2005, Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction, Proc. Natl. Acad. Sci. U. S. A., 102, 11870, 10.1073/pnas.0502488102

Medina, 1997, SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation, Glycobiology, 8, 383, 10.1093/glycob/8.4.383

Wells, 2004, O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits, J. Biol. Chem., 279, 38466, 10.1074/jbc.M406481200

Lefebvre, 1999, Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line, Biochim. Biophys. Acta, 1472, 71, 10.1016/S0304-4165(99)00105-1

Gould, 2005, Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs, Neuropsychopharmacology, 30, 1223, 10.1038/sj.npp.1300731

Woodgett, 2001, Judging a protein by more than its name: GSK-3, Sci. STKE, 2001, re12, 10.1126/stke.2001.100.re12

Ong, 2005, Mass spectrometry-based proteomics turns quantitative, Nat. Chem. Biol., 1, 252, 10.1038/nchembio736

Ibarrola, 2004, A novel proteomic approach for specific identification of tyrosine kinase substrates using [13C]tyrosine, J. Biol. Chem., 279, 15805, 10.1074/jbc.M311714200

Bose, 2006, Phosphoproteomic analysis of Her2/neu signaling and inhibition, Proc. Natl. Acad. Sci. U. S. A., 103, 9773, 10.1073/pnas.0603948103

Comer, 2001, Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine, Anal. Biochem., 293, 169, 10.1006/abio.2001.5132

Goto, 1997, A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function, Genes Dev., 11, 726, 10.1101/gad.11.6.726

Wells, 2002, Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications, Mol. Cell. Proteomics, 1, 791, 10.1074/mcp.M200048-MCP200

Stambolic, 1996, Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells, Curr. Biol., 6, 1664, 10.1016/S0960-9822(02)70790-2

Zeng, 1997, The mouse fused locus encodes axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation, Cell, 90, 181, 10.1016/S0092-8674(00)80324-4

Zhang, 2003, Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3, J. Biol. Chem., 278, 33067, 10.1074/jbc.M212635200

Mullis, 1990, Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins, J. Virol., 64, 5317, 10.1128/jvi.64.11.5317-5323.1990

Dreyfuss, 1993, hnRNP proteins and the biogenesis of mRNA, Annu. Rev. Biochem., 62, 289, 10.1146/annurev.bi.62.070193.001445

Krecic, 1999, hnRNP complexes: composition, structure, and function, Curr. Opin. Cell Biol., 11, 363, 10.1016/S0955-0674(99)80051-9

DeMaria, 1996, AUF1 binding affinity to A + U-rich elements correlates with rapid mRNA degradation, J. Biol. Chem., 271, 12179, 10.1074/jbc.271.21.12179

Kiledjian, 1997, Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the α-globin mRNA stability complex, Mol. Cell. Biol., 17, 4870, 10.1128/MCB.17.8.4870

Michelotti, 1996, Heterogeneous nuclear ribonucleoprotein K is a transcription factor, Mol. Cell. Biol., 16, 2350, 10.1128/MCB.16.5.2350

Miau, 1998, Identification of heterogeneous nuclear ribonucleoprotein K (hnRNP K) as a repressor of C/EBP β-mediated gene activation, J. Biol. Chem., 273, 10784, 10.1074/jbc.273.17.10784

Idriss, 1994, Regulation of in vitro nucleic acid strand annealing activity of heterogeneous nuclear ribonucleoprotein protein A1 by reversible phosphorylation, Biochemistry, 33, 11382, 10.1021/bi00203a037

Tolnay, 2002, Protein kinase A enhances, whereas glycogen synthase kinase-3β inhibits, the activity of the exon 2-encoded transactivator domain of heterogeneous nuclear ribonucleoprotein D in a hierarchical fashion, Biochem. J., 363, 127, 10.1042/bj3630127

Soulard, 1993, hnRNP G: sequence and characterization of a glycosylated RNA-binding protein, Nucleic Acids Res., 21, 4210, 10.1093/nar/21.18.4210

Brill, 2004, Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry, Anal. Chem., 76, 2763, 10.1021/ac035352d

Stone, 2003, Basal and hydrogen peroxide stimulated sites of phosphorylation in heterogeneous nuclear ribonucleoprotein C1/C2, Biochemistry, 42, 1301, 10.1021/bi0268091

Omary, 2006, “Heads and tails” of intermediate filament phosphorylation: multiple sites and functional insights, Trends Biochem. Sci., 31, 383, 10.1016/j.tibs.2006.05.008

Tsujimura, 1994, Visualization and function of vimentin phosphorylation by cdc2 kinase during mitosis, J. Biol. Chem., 269, 31097, 10.1016/S0021-9258(18)47395-4

Li, 2006, Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signaling, J. Biol. Chem., 281, 34716, 10.1074/jbc.M607715200

Rochat, 2004, Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy, Mol. Biol. Cell, 15, 4544, 10.1091/mbc.e03-11-0816

Greis, 1996, Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by β-elimination and tandem electrospray mass spectrometry, Anal. Chem., 234, 38

Greis, 1994, Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952, J. Virol., 68, 8339, 10.1128/jvi.68.12.8339-8349.1994

Khidekel, 2004, Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain, Proc. Natl. Acad. Sci. U. S. A., 101, 13132, 10.1073/pnas.0403471101

Ball, 2006, Identification of the major site of O-linked β-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1, Mol. Cell. Proteomics, 5, 313, 10.1074/mcp.M500314-MCP200

Vosseller, 2006, O-Linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry, Mol. Cell. Proteomics, 5, 923, 10.1074/mcp.T500040-MCP200

Wilson, 1993, The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein, Cell, 74, 115, 10.1016/0092-8674(93)90299-6

Kristie, 1993, Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus α-trans-induction factor (VP16), J. Biol. Chem., 268, 6525, 10.1016/S0021-9258(18)53282-8

Delehouzee, 2005, GABP, HCF-1 and YY1 are involved in Rb gene expression during myogenesis, Genes Cells, 10, 717, 10.1111/j.1365-2443.2005.00873.x

Luciano, 2003, HCF-1 functions as a coactivator for the zinc finger protein Krox20, J. Biol. Chem., 278, 51116, 10.1074/jbc.M303470200

Wysocka, 2001, Developmental and cell-cycle regulation of Caenorhabditis elegans HCF phosphorylation, Biochemistry, 40, 5786, 10.1021/bi010086o

Ajuh, 2002, A novel function for human factor C1 (HCF-1), a host protein required for herpes simplex virus infection, in pre-mRNA splicing, EMBO J., 21, 6590, 10.1093/emboj/cdf652

Wysocka, 2003, Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1, Genes Dev., 17, 896, 10.1101/gad.252103

Wilson, 2000, HCF-1 amino- and carboxy-terminal subunit association through two separate sets of interaction modules: involvement of fibronectin type 3 repeats, Mol. Cell. Biol., 20, 6721, 10.1128/MCB.20.18.6721-6730.2000

LaBoissiere, 1999, HCF-dependent nuclear import of VP16, EMBO J., 18, 480, 10.1093/emboj/18.2.480

Mahajan, 2002, Interaction of HCF-1 with a cellular nuclear export factor, J. Biol. Chem., 277, 44292, 10.1074/jbc.M205440200

Khurana, 2004, A protein sequestering system reveals control of cellular programs by the transcriptional coactivator HCF-1, J. Biol. Chem., 279, 33673, 10.1074/jbc.M401255200

Ikonomov, 1999, Molecular mechanisms underlying mode stabilization in manic-depressive illness: the phenotype challenge, Am. J. Psychiatry, 156, 1506, 10.1176/ajp.156.10.1506

Bhat, 2003, Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418, J. Biol. Chem., 278, 45937, 10.1074/jbc.M306268200

Lefebvre, 2001, Identification of N-acetyl-d-glucosamine-specific lectins from rat liver cytosolic and nuclear compartments as heat-shock proteins, Biochem. J., 360, 179, 10.1042/bj3600179

Chou, 1992, Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18, J. Biol. Chem., 267, 3901, 10.1016/S0021-9258(19)50611-1